Skip to main content
. 2021 Jan 20;12(1):101. doi: 10.1038/s41419-021-03400-9

Fig. 2. K270 is the major SUMOylation site in PKM2.

Fig. 2

A In vitro SUMOylation of PKM2. Recombinant wild type (WT) or K270R mutant His-tagged PKM2 were incubated with recombinant SUMO1 in the presence of purified E1(SAE1/UBA2) and E2(UBC9) with or without SENP1. SUMO1 modification were detected using antibody against PKM2 or SUMO1. K, lysine; R, arinine; E, glutamic acid; M, methionine. B SUMOylated PKM2 peptide identified by MS. Recombinant PKM2 protein was digested by trypsin and subjected to LC-MS/MS for identification. The lysine conjugated with QTGG remnant indicates the SUMOylation site. C WT or K270R mutant (KR) Flag-tagged PKM2 were infected into NB4 cells that endogenous PKM2 were depleted. The SUMO1 modification were measured by IP with anti-PKM2 antibody. D, E Multiple-reaction monitoring mass spectrometry(MRM-MS) analysis of SUMOylated PKM2 in leukemia cell lines (D) and primary samples from patients with AML (E).